News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,079 Results
Type
Article (144)
Company Profile (1)
Press Release (934)
Section
Business (361)
Career Advice (2)
Deals (52)
Drug Development (244)
FDA (19)
Job Trends (44)
News (645)
Policy (53)
Tag
Academia (4)
Alliances (65)
ALS (3)
Alzheimer's disease (10)
Antibody-drug conjugate (ADC) (2)
Approvals (24)
Bankruptcy (1)
Best Places to Work (33)
Biotechnology (1)
Cancer (3)
Cardiovascular disease (1)
Career advice (2)
Cell therapy (2)
Clinical research (193)
Collaboration (6)
Compensation (2)
COVID-19 (5)
C-suite (2)
Data (11)
Depression (1)
Diabetes (1)
Diagnostics (3)
Drug discovery (3)
Earnings (144)
Editorial (1)
Events (134)
Executive appointments (3)
FDA (27)
Frontotemporal dementia (1)
Funding (3)
Gene editing (1)
Gene therapy (5)
GLP-1 (7)
Government (8)
Guidances (2)
Healthcare (67)
Huntington's disease (3)
Immunology and inflammation (1)
Infectious disease (6)
Inflammatory bowel disease (1)
IPO (39)
Job creations (11)
Job search strategy (2)
Layoffs (4)
Legal (1)
Longevity (1)
Manufacturing (3)
MASH (2)
Medical device (5)
Medtech (5)
Mergers & acquisitions (15)
Metabolic disorders (3)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (15)
NextGen: Class of 2026 (6)
Non-profit (3)
Opinion (5)
People (150)
Phase 1 (39)
Phase 2 (81)
Phase 3 (98)
Pipeline (12)
Postmarket research (4)
Preclinical (31)
Radiopharmaceuticals (1)
Rare diseases (2)
Real estate (2)
Regulatory (56)
Schizophrenia (1)
Series A (1)
Series B (1)
Spinal muscular atrophy (2)
Startups (7)
Vaccines (6)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (53)
2026 (5)
2025 (53)
2024 (83)
2023 (82)
2022 (83)
2021 (81)
2020 (85)
2019 (71)
2018 (62)
2017 (75)
2016 (62)
2015 (53)
2014 (42)
2013 (43)
2012 (48)
2011 (37)
2010 (30)
Location
Africa (2)
Asia (47)
Australia (6)
California (18)
China (1)
Colorado (1)
Europe (112)
Florida (1)
Georgia (1)
Indiana (1)
Japan (4)
Massachusetts (33)
Missouri (1)
Nevada (1)
New York (10)
Northern California (7)
Oregon (1)
Pennsylvania (3)
South America (4)
Southern California (9)
United States (70)
Washington State (1)
1,079 Results for "voyager therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Voyager Throws 30 Staff Overboard After Novartis Sinks Two Programs
Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last month. Projects under the deal for spinal muscular atrophy and Huntington’s disease continue to advance.
December 18, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Voyager Reports Third Quarter 2025 Financial and Operating Results
November 11, 2025
·
16 min read
Press Releases
Transition Bio and Voyager Announce Collaboration to Advance Small Molecules Targeting TDP-43 in ALS and Frontotemporal Dementia
November 11, 2025
·
7 min read
Press Releases
Voyager to Present at Upcoming September 2025 Investor Conferences
August 26, 2025
·
2 min read
Press Releases
Voyager Reports Second Quarter 2025 Financial and Operating Results
August 7, 2025
·
14 min read
Press Releases
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025
·
12 min read
Press Releases
Voyager Reports First Quarter 2025 Financial and Operating Results
May 7, 2025
·
14 min read
Press Releases
Voyager Adds Fourth Wholly-Owned Alzheimer’s Disease Program to Pipeline, Complementing Existing Tau and Amyloid Assets with New APOE Approach
July 17, 2025
·
8 min read
Press Releases
Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting
April 29, 2025
·
8 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 108
Next
